Nurix Therapeutics Stock Price Patterns
| NRIX Stock | USD 15.79 0.31 2.00% |
Momentum 40
Sell Extended
Oversold | Overbought |
EPS Estimate Current Year (3.13) | EPS Estimate Next Year (3.01) | Wall Street Target Price 30 | EPS Estimate Current Quarter (0.92) | Quarterly Revenue Growth 0.022 |
Using Nurix Therapeutics hype-based prediction, you can estimate the value of Nurix Therapeutics from the perspective of Nurix Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Nurix Therapeutics using Nurix Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Nurix using crowd psychology based on the activity and movement of Nurix Therapeutics' stock price.
Nurix Therapeutics Short Interest
An investor who is long Nurix Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Nurix Therapeutics and may potentially protect profits, hedge Nurix Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 12.8954 | Short Percent 0.1636 | Short Ratio 11.39 | Shares Short Prior Month 15.2 M | 50 Day MA 18.2388 |
Nurix Therapeutics Hype to Price Pattern
Investor biases related to Nurix Therapeutics' public news can be used to forecast risks associated with an investment in Nurix. The trend in average sentiment can be used to explain how an investor holding Nurix can time the market purely based on public headlines and social activities around Nurix Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Nurix Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Nurix Therapeutics.
Nurix Therapeutics Implied Volatility | 1.81 |
Nurix Therapeutics' implied volatility exposes the market's sentiment of Nurix Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Nurix Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Nurix Therapeutics stock will not fluctuate a lot when Nurix Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Nurix Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Nurix because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Nurix Therapeutics after-hype prediction price | USD 15.77 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Nurix contract
Based on the Rule 16, the options market is currently suggesting that Nurix Therapeutics will have an average daily up or down price movement of about 0.11% per day over the life of the 2026-04-17 option contract. With Nurix Therapeutics trading at USD 15.79, that is roughly USD 0.0179 . If you think that the market is fully incorporating Nurix Therapeutics' daily price movement you should consider acquiring Nurix Therapeutics options at the current volatility level of 1.81%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Nurix Therapeutics Basic Forecasting Models to cross-verify your projections. Nurix Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Nurix Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nurix Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Nurix Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Nurix Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Nurix Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nurix Therapeutics' historical news coverage. Nurix Therapeutics' after-hype downside and upside margins for the prediction period are 11.72 and 19.82, respectively. We have considered Nurix Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Nurix Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Nurix Therapeutics is based on 3 months time horizon.
Nurix Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Nurix Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nurix Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nurix Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.02 | 4.05 | 0.02 | 0.00 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
15.79 | 15.77 | 0.13 |
|
Nurix Therapeutics Hype Timeline
Nurix Therapeutics is now traded for 15.79. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.0. Nurix is forecasted to decline in value after the next headline, with the price expected to drop to 15.77. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.13%, whereas the daily expected return is now at -0.02%. The volatility of related hype on Nurix Therapeutics is about 2700.0%, with the expected price after the next announcement by competition of 15.79. About 98.0% of the company shares are owned by institutional investors. The book value of Nurix Therapeutics was now reported as 5.29. The company recorded a loss per share of 3.05. Nurix Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Nurix Therapeutics Basic Forecasting Models to cross-verify your projections.Nurix Therapeutics Related Hype Analysis
Having access to credible news sources related to Nurix Therapeutics' direct competition is more important than ever and may enhance your ability to predict Nurix Therapeutics' future price movements. Getting to know how Nurix Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nurix Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KOD | Kodiak Sciences | 0.49 | 9 per month | 3.97 | 0.07 | 9.66 | (6.87) | 23.68 | |
| PHAT | Phathom Pharmaceuticals | (0.07) | 9 per month | 0.00 | (0.07) | 6.16 | (6.14) | 24.16 | |
| XNCR | Xencor Inc | (0.25) | 7 per month | 0.00 | (0.09) | 6.33 | (5.08) | 16.84 | |
| URGN | UroGen Pharma | 0.53 | 10 per month | 0.00 | (0.04) | 5.71 | (5.50) | 21.64 | |
| TNGX | Tango Therapeutics | (0.65) | 9 per month | 3.01 | 0.15 | 11.29 | (5.65) | 31.20 | |
| SEPN | Septerna Common Stock | (0.61) | 6 per month | 3.08 | 0.13 | 7.53 | (5.25) | 27.98 | |
| EYPT | Eyepoint Pharmaceuticals | (0.87) | 9 per month | 3.29 | 0.07 | 8.15 | (4.98) | 23.49 | |
| KURA | Kura Oncology | (0.40) | 9 per month | 0.00 | (0.08) | 5.01 | (5.77) | 22.83 | |
| FTRE | Fortrea Holdings | (0.26) | 8 per month | 5.15 | (0.01) | 7.63 | (9.88) | 29.57 | |
| BBOT | BridgeBio Oncology Therapeutics | 0.59 | 9 per month | 0.00 | (0.03) | 9.92 | (7.04) | 31.80 |
Nurix Therapeutics Additional Predictive Modules
Most predictive techniques to examine Nurix price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nurix using various technical indicators. When you analyze Nurix charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Nurix Therapeutics Predictive Indicators
The successful prediction of Nurix Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Nurix Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Nurix Therapeutics based on analysis of Nurix Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Nurix Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nurix Therapeutics's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Current Ratio | 6.46 | 7.02 | 6.32 | 3.65 | Net Debt To EBITDA | 0.4 | 0.78 | 0.9 | 1.33 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nurix Stock Analysis
When running Nurix Therapeutics' price analysis, check to measure Nurix Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix Therapeutics is operating at the current time. Most of Nurix Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nurix Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nurix Therapeutics' price. Additionally, you may evaluate how the addition of Nurix Therapeutics to your portfolios can decrease your overall portfolio volatility.